Meera K Shenoy1,2, Shoko Iwai1, Din L Lin1, William Worodria3, Irene Ayakaka3, Patrick Byanyima3, Sylvia Kaswabuli3, Serena Fong4, Stephen Stone4, Emily Chang4,5, J Lucian Davis6,7, Ali Ahmad Faruqi1, Mark R Segal8, Laurence Huang4,5, Susan V Lynch1. 1. 1 Division of Gastroenterology, Department of Medicine. 2. 2 Biomedical Sciences Graduate Program. 3. 3 Infectious Diseases Research Collaboration, Mulago Hospital, Makerere University, Kampala, Uganda. 4. 4 HIV, Infectious Diseases and Global Medicine Division, San Francisco General Hospital. 5. 5 Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, and. 6. 6 Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut; and. 7. 7 Pulmonary, Critical Care, and Sleep Medicine Section, Yale School of Medicine, New Haven, Connecticut. 8. 8 Division of Biostatistics, University of California San Francisco, San Francisco, California.
Abstract
RATIONALE: The potential role of the airway microbiota in dictating immune responses and infection outcomes in HIV-associated pneumonia is largely unknown. OBJECTIVES: To investigate whether microbiologically and immunologically distinct subsets of patients with HIV and pneumonia exist and are related to mortality. METHODS: Bronchoalveolar lavage samples from Ugandan patients with HIV and pneumonia (n = 182) were obtained at study enrollment (following antibiotic treatment); patient demographics including 8- and 70-day mortality were collected. Lower airway bacterial community composition was assessed via amplification and sequencing of the V4 region of the 16S ribosomal RNA gene. Host immune response gene expression profiles were generated by quantitative polymerase chain reaction using RNA extracted from bronchoalveolar lavage fluid. Liquid and gas chromatography mass spectrometry was used to profile serum metabolites. MEASUREMENTS AND MAIN RESULTS: Based on airway microbiome composition, most patients segregated into three distinct groups, each of which were predicted to encode metagenomes capable of producing metabolites characteristically enriched in paired serum samples from these patients. These three groups also exhibited differences in mortality; those with the highest rate had increased ceftriaxone administration and culturable Aspergillus, and demonstrated significantly increased induction of airway T-helper cell type 2 responses. The group with the lowest mortality was characterized by increased expression of T-cell immunoglobulin and mucin domain 3, which down-regulates T-helper cell type 1 proinflammatory responses and is associated with chronic viral infection. CONCLUSIONS: These data provide evidence that compositionally and structurally distinct lower airway microbiomes are associated with discrete local host immune responses, peripheral metabolic reprogramming, and different rates of mortality.
RATIONALE: The potential role of the airway microbiota in dictating immune responses and infection outcomes in HIV-associated pneumonia is largely unknown. OBJECTIVES: To investigate whether microbiologically and immunologically distinct subsets of patients with HIV and pneumonia exist and are related to mortality. METHODS: Bronchoalveolar lavage samples from Ugandan patients with HIV and pneumonia (n = 182) were obtained at study enrollment (following antibiotic treatment); patient demographics including 8- and 70-day mortality were collected. Lower airway bacterial community composition was assessed via amplification and sequencing of the V4 region of the 16S ribosomal RNA gene. Host immune response gene expression profiles were generated by quantitative polymerase chain reaction using RNA extracted from bronchoalveolar lavage fluid. Liquid and gas chromatography mass spectrometry was used to profile serum metabolites. MEASUREMENTS AND MAIN RESULTS: Based on airway microbiome composition, most patients segregated into three distinct groups, each of which were predicted to encode metagenomes capable of producing metabolites characteristically enriched in paired serum samples from these patients. These three groups also exhibited differences in mortality; those with the highest rate had increased ceftriaxone administration and culturable Aspergillus, and demonstrated significantly increased induction of airway T-helper cell type 2 responses. The group with the lowest mortality was characterized by increased expression of T-cell immunoglobulin and mucin domain 3, which down-regulates T-helper cell type 1 proinflammatory responses and is associated with chronic viral infection. CONCLUSIONS: These data provide evidence that compositionally and structurally distinct lower airway microbiomes are associated with discrete local host immune responses, peripheral metabolic reprogramming, and different rates of mortality.
Authors: T Z DeSantis; P Hugenholtz; N Larsen; M Rojas; E L Brodie; K Keller; T Huber; D Dalevi; P Hu; G L Andersen Journal: Appl Environ Microbiol Date: 2006-07 Impact factor: 4.792
Authors: Ola Kilsgård; Pia Andersson; Martin Malmsten; Sara L Nordin; Helena M Linge; Mette Eliasson; Eva Sörenson; Jonas S Erjefält; Johan Bylund; Anders I Olin; Ole E Sørensen; Arne Egesten Journal: Am J Respir Cell Mol Biol Date: 2011-09-29 Impact factor: 6.914
Authors: Tetsuya Homma; Atsushi Kato; Bharat Bhushan; James E Norton; Lydia A Suh; Roderick G Carter; Dave S Gupta; Robert P Schleimer Journal: Am J Respir Cell Mol Biol Date: 2016-01 Impact factor: 6.914
Authors: Lucy Golden-Mason; Brent E Palmer; Nasim Kassam; Lisa Townshend-Bulson; Stephen Livingston; Brian J McMahon; Nicole Castelblanco; Vijay Kuchroo; David R Gretch; Hugo R Rosen Journal: J Virol Date: 2009-07-08 Impact factor: 5.103
Authors: Catherine S Marshall; Andrea J Curtis; Tim Spelman; Daniel P O'Brien; Jane Greig; Leslie Shanks; Philipp du Cros; Esther C Casas; Marcio Silveira da Fonseca; Eugene Athan; Julian H Elliott Journal: PLoS One Date: 2013-07-23 Impact factor: 3.240
Authors: Christopher J Stewart; Jonathan M Mansbach; Matthew C Wong; Nadim J Ajami; Joseph F Petrosino; Carlos A Camargo; Kohei Hasegawa Journal: Am J Respir Crit Care Med Date: 2017-10-01 Impact factor: 21.405
Authors: Leopoldo N Segal; Jose C Clemente; Yonghua Li; Chunhai Ruan; Jane Cao; Mauricio Danckers; Alison Morris; Sarah Tapyrik; Benjamin G Wu; Philip Diaz; Gregory Calligaro; Rodney Dawson; Richard N van Zyl-Smit; Keertan Dheda; William N Rom; Michael D Weiden Journal: Cell Host Microbe Date: 2017-03-30 Impact factor: 21.023
Authors: Ariane R Panzer; Susan V Lynch; Chaz Langelier; Jason D Christie; Kathryn McCauley; Mary Nelson; Christopher K Cheung; Neal L Benowitz; Mitchell J Cohen; Carolyn S Calfee Journal: Am J Respir Crit Care Med Date: 2018-03-01 Impact factor: 21.405
Authors: Keehoon Lee; Steven D Pletcher; Susan V Lynch; Andrew N Goldberg; Emily K Cope Journal: Front Cell Infect Microbiol Date: 2018-05-23 Impact factor: 5.293